Atlas Lithium Corporation — Form 10-Q Summary
Reporting period: Three months ended March 31, 2023. The unaudited consolidated statements are prepared under U.S. GAAP. Atlas Lithium is a Brazil-focused mineral exploration and development company, with lithium as its principal focus; it had not generated material product revenue.
Key financial results and position
| Metric | Q1 2023 | Q1 2022 / comparison |
|---|---|---|
| Revenue | $0 | $477 |
| Operating expenses | $4.48 million | $827,317 |
| Net loss | $4.47 million | $834,743 |
| Net loss attributable to Atlas shareholders | $3.97 million | $531,490 |
| Basic and diluted loss per share | $0.60 | $0.12 |
| Cash used in operating activities | $3.66 million | $506,071 |
| Cash used in investing activities | $1.28 million | $152,998 |
| Cash provided by financing activities | $9.56 million | $622,999 |
With no meaningful revenue, gross margin is not informative. At March 31, cash and cash equivalents were $4.99 million, working capital was $2.60 million, total assets were $12.39 million, and total liabilities were $2.54 million. There was no material conventional debt balance disclosed; current liabilities were $2.46 million, including $1.81 million payable for mineral rights. Intangible mineral-rights assets totaled $6.96 million. Management said cash on hand was expected to fund working capital and capital expenditures through at least March 2024, while warning that additional financing may be needed.
Material changes and financing
- Operating expenses increased substantially year over year. Management cited approximately $1.03 million of non-recurring Nasdaq offering/listing costs, approximately $712,000 of compensation costs tied to contractual obligations (some non-recurring), higher stock-based compensation, and $1.03 million of exploration expense.
- The company raised $9.49 million net from common-stock sales during the quarter, including a January underwritten offering with $4.66 million gross proceeds, a $4.00 million Regulation S placement, and $831,834 gross proceeds from sales to Triton Funds. Financing also included $75,000 from a subsidiary share sale.
- Common shares outstanding increased during the quarter. The filing reports 6,728,062 shares on the balance sheet at March 31, while the equity statement reports 6,738,062; it separately reports 9,706,126 shares outstanding as of May 15. These figures warrant reconciliation.
Operations, outlook, and notable items
- Atlas was advancing its Minas Gerais Lithium Project in Brazil, particularly the Neves Project. It reported 10 active drills and 19,017 meters drilled as of May 4, 2023, compared with 1,213 meters at the time of its earlier technical report. A maiden resource report was expected in Q3 2023; no mineral reserves had been established.
- A metallurgical study announced in April reported a 6.04% Li2O concentrate grade, 0.53% Fe2O3, and 70% lithium recovery from a representative sample. These test results do not establish commercial-scale performance or project economics.
- The company was planning a potential 150,000-ton-per-year concentrate plant. A non-binding, non-exclusive MOU with Mitsui contemplated up to $65 million of milestone-based funding in exchange for potential rights to purchase up to 100% of future plant output; it was not a committed financing or binding offtake agreement.
- On May 2, 2023, after quarter-end, Atlas sold a 3% gross-revenue royalty on products from specified properties for $20 million cash. The agreement also gives the buyer a one-year option to acquire an additional royalty for $5 million. The royalty encumbers future revenue from the covered properties.
- The filing describes post-quarter corporate actions to correct and validate the 1-for-750 reverse split paperwork and restore authorized share capital, with an intended reduction of authorized common shares to 200 million. The filings with Nevada were expected no earlier than May 25, 2023.
- Principal risks include exploration and development uncertainty, permitting and environmental requirements in Brazil, lithium-price and currency exposure, ongoing cash burn and dependence on external financing, potential equity dilution, and concentrated voting control. The CEO’s Series A preferred share carries 51% of total voting power. Atlas also disclosed May 2023 short-seller allegations and potential securities litigation; it stated that it believed the allegations were without merit and that no litigation had been filed at the time described.
Most important facts for investors to verify
- Reconcile the inconsistent March 31 common-share count in the balance sheet and equity statement, and confirm subsequent share issuance and dilution.
- Review completion and findings of the maiden resource report, and distinguish exploration results and metallurgical testwork from proven reserves, feasibility, permits, and commercial production.
- Confirm the $20 million royalty proceeds, covered mineral rights, ongoing 3% revenue burden, and status of the additional-royalty option.
- Verify whether the Mitsui MOU becomes binding, whether milestone funding is secured, and whether plant construction and development costs are funded.
- Monitor cash consumption against management’s stated runway and assess any further financing needs, especially given the filing’s stated risk that unavailable financing could force operations to be curtailed.
- Confirm the effective status and final terms of the reverse-split correction and authorized-share amendments.